文献速递复苏、休克与脓毒症创伤与烧伤

偏远环境下院前复苏应考虑白蛋白吗?兔前瞻性随机生存研究

Should Albumin be Considered for Prehospital Resuscitation in Austere Environments? A Prospective Randomized Survival Study in Rabbits.
PubMed 文献 · Shock · 2020-01-01
一句话结论兔重度失血性休克模型中,限量全血、新鲜冰冻血浆或5%人白蛋白行2小时允许性低血压复苏均实现长期存活,白蛋白可考虑用于血液制品不可及或不被接受的院前复苏。

研究在去甲静脉麻醉自主呼吸新西兰白兔中放血约40%血容量制造重度失血性休克(平均动脉压约20 mmHg),15分钟后以12.5 mL/kg的兔全血、兔新鲜冰冻血浆或5%人白蛋白复苏至平均动脉压60 mmHg并维持2小时,随后充分复苏、手术修复并观察8天。三组均实现完全康复和8天存活(除一例外),白蛋白与血浆在止血和复苏效果上除纤维蛋白原外无差异,白蛋白和血浆延长出血时间而全血不延长。作者认为5%人白蛋白等渗、等胶体渗透压、即用、稳定且与所有血型兼容,在血液制品不可获得或不接受时应考虑用于院前复苏。

要点

  • 兔重度失血性休克(平均动脉压约20 mmHg)后,12.5 mL/kg的5%人白蛋白复苏至平均动脉压60 mmHg并维持2小时,最终实现8天存活。
  • 白蛋白组与新鲜冰冻血浆组在止血和复苏效果上除纤维蛋白原外无差异,两者均延长出血时间;全血不延长出血时间。
  • 全血达到目标平均动脉压所需体积更少(P<0.05 vs 白蛋白),但允许性低血压期间平均动脉压下降更明显(P<0.01 vs 白蛋白)。
  • 全血提供更高的红细胞压积和血小板,但降低乳酸的速度并不快于其他液体。
  • 作者认为5%人白蛋白等渗、等胶体渗透压、即用、稳定且与所有血型兼容,在血液制品不可获得或不接受时应考虑用于院前复苏。

适用人群与场景

  • 静脉麻醉、自主呼吸的新西兰白兔,体重3.0 kg-3.5 kg,放血约40%血容量造成重度失血性休克(平均动脉压约20 mmHg)。
  • 未治疗组(n=6)同样纳入观察。

诊断标准与关键阈值

  • 重度失血性休克模型:移除约40%血容量后平均动脉压约20 mmHg。
  • 允许性低血压复苏目标:平均动脉压60 mmHg。

处置流程与药物剂量

  • 失血性休克后15分钟开始允许性低血压复苏,使用限量12.5 mL/kg的兔全血、兔新鲜冰冻血浆或5%人白蛋白,目标平均动脉压60 mmHg,维持2小时(每组n=8)。
  • 允许性低血压复苏2小时后行充分复苏(血液+乳酸林格液),手术修复,恢复观察8天。
  • 基线和允许性低血压复苏后10分钟测量肝出血时间。

研究设计与关键结果

  • 研究类型:前瞻性随机生存研究,动物(兔)实验;每组n=8,未治疗组n=6。
  • 失血性休克后乳酸和碱剩余分别升至8.2±1.6 mM和12.9±3.1 mM,组间无差异。
  • 全血达到目标平均动脉压所需体积更少(P<0.05 vs 白蛋白),但允许性低血压期间平均动脉压下降(P<0.01 vs 白蛋白)。
  • 全血提供更高的红细胞压积和血小板,但降低乳酸速度不比其他液体快。
  • 新鲜冰冻血浆与白蛋白相比,除纤维蛋白原更高外,止血或复苏效果无差异。
  • 白蛋白和新鲜冰冻血浆延长出血时间,全血不延长。
  • 未治疗兔在休克期间或之后不久死亡;所有治疗兔除一例外均康复并存活8天,血液检查正常,组织学相似。

证据类型、等级与局限

  • 证据类型:前瞻性随机动物(兔)生存研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,5%人白蛋白等渗、等胶体渗透压、即用、稳定且与所有血型兼容,在血液制品不可获得或不接受的院前环境中应考虑用于复苏。
  • 兔模型中除出血时间外,全血、新鲜冰冻血浆与白蛋白三种液体在允许性低血压复苏后无临床显著差异,白蛋白和血浆延长出血时间而全血不延长。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The new guidelines for prehospital care of combat casualties in shock recommend administration of whole blood or blood components to increase blood pressure to a permissible hypotensive level (i.e., hypotensive resuscitation [HR]). We investigated if 2 h of HR using limited volumes of whole blood, plasma, or albumin would lead to full recovery and long-term survival of rabbits subjected to severe hemorrhagic shock (HS).

METHODS: Following instrumentation, laparotomy was performed on IV-anesthetized spontaneously breathing New Zealand white rabbits (3.0 kg -3.5 kg). Next, ∼40% of rabbits' blood volume was removed producing HS (mean arterial pressure [MAP]∼20 mm Hg). Fifteen minutes later, rabbits were resuscitated with a limited volume (12.5 mL/kg) of rabbit whole blood (fresh whole blood [FWB]), rabbit fresh frozen plasma (FFP), or 5% human albumin (ALB) to a target pressure (MAP) of 60 mm Hg (n=8/grp) and monitored for 2 h. Liver bleeding time was measured at baseline and 10 min after HR. Subsequently, animals were fully resuscitated (blood + lactated Ringer [LR]), surgically repaired, and recovered for 8 days. An untreated group (n = 6) was also included.

RESULTS: Following HS, lactate and base deficit levels were increased to 8.2 ± 1.6 and 12.9 ± 3.1 mM respectively with no difference among groups. A lower volume of FWB volume was required to reach the target MAP (P < 0.05 vs. ALB) but MAP declined during the HR period (P < 0.01 vs. ALB). FWB provided higher hematocrit and platelets but it did not reduce lactate level faster than other fluids. Beside higher fibrinogen, no differences were found in hemostatic or resuscitative effects of FFP versus ALB. Bleeding time was prolonged with ALB and FFP fluids but unchanged with FWB. Untreated rabbits died during shock or shortly after. All treated rabbits except one recovered and lived for 8 days with normal blood tests and similar tissue histology.

CONCLUSIONS: Two hours of HR using a limited volume of FWB, FFP, or ALB led to full recovery and long-term survival of rabbits subjected to HS. Apart from bleeding time, no clinically significant differences were found among the three fluids. Five percent human albumin solutions are isotonic, iso-oncotic, ready-to-use, stable, and compatible with all blood types and should be considered for prehospital resuscitation where blood products are not available or not accepted.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Kheirabadi BS, Miranda N, Terrazas IB, et al. Should Albumin be Considered for Prehospital Resuscitation in Austere Environments? A Prospective Randomized Survival Study in Rabbits. Shock. 2020. PMID: 31743300. doi:10.1097/SHK.0000000000001480

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。